AAAAAA

   
Results: 1-12 |
Results: 12
EFFECT OF ATORVASTATIN VERSUS SIMVASTATIN ON LIPID PROFILE AND PLASMA-FIBRINOGEN IN PATIENTS WITH HYPERCHOLESTEROLEMIA - A PILOT, RANDOMIZED, DOUBLE-BLIND, DOSE-TITRATING STUDY
Authors: ATHYROS VG PAPAGEORGIOU AA HATZIKONSTANDINOU HA ATHYROU VV KONTOPOULOS AG
Citation: Vg. Athyros et al., EFFECT OF ATORVASTATIN VERSUS SIMVASTATIN ON LIPID PROFILE AND PLASMA-FIBRINOGEN IN PATIENTS WITH HYPERCHOLESTEROLEMIA - A PILOT, RANDOMIZED, DOUBLE-BLIND, DOSE-TITRATING STUDY, Clinical drug investigation, 16(3), 1998, pp. 219-227
EFFECT OF ALDOSE REDUCTASE INHIBITION ON HEART-RATE-VARIABILITY IN PATIENTS WITH SEVERE OR MODERATE DIABETIC AUTONOMIC NEUROPATHY
Authors: DIDANGELOS TP ATHYROS VG KARAMITSOS DT PAPAGEORGIOU AA KOURTOGLOU GI KONTOPOULOS AG
Citation: Tp. Didangelos et al., EFFECT OF ALDOSE REDUCTASE INHIBITION ON HEART-RATE-VARIABILITY IN PATIENTS WITH SEVERE OR MODERATE DIABETIC AUTONOMIC NEUROPATHY, Clinical drug investigation, 15(2), 1998, pp. 111-121
EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE POWER SPECTRUM OF HEART-RATE-VARIABILITY IN POSTMYOCARDIAL INFARCTION PATIENTS
Authors: KONTOPOULOS AG ATHYROS VG PAPAGEORGIOU AA SKEBERIS VM BASAYIANNIS EC BOUDOULAS H
Citation: Ag. Kontopoulos et al., EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON THE POWER SPECTRUM OF HEART-RATE-VARIABILITY IN POSTMYOCARDIAL INFARCTION PATIENTS, Coronary artery disease, 8(8), 1997, pp. 517-524
EFFECT OF CHRONIC QUINAPRIL ADMINISTRATION ON HEART-RATE-VARIABILITY IN PATIENTS WITH DIABETIC AUTONOMIC NEUROPATHY
Authors: KONTOPOULOS AG ATHYROS VG DIDANGELOS TP PAPAGEORGIOU AA AVRAMIDIS MJ MAYROUDI MC KARAMITSOS DT
Citation: Ag. Kontopoulos et al., EFFECT OF CHRONIC QUINAPRIL ADMINISTRATION ON HEART-RATE-VARIABILITY IN PATIENTS WITH DIABETIC AUTONOMIC NEUROPATHY, Diabetes care, 20(3), 1997, pp. 355-361
SAFETY AND EFFICACY OF LONG-TERM STATIN-FIBRATE COMBINATIONS IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPIDEMIA
Authors: ATHYROS VG PAPAGEORGIOU AA HATZIKONSTANDINOU HA DIDANGELOS TP CARINA MV KRANITSAS DF KONTOPOULOS AG
Citation: Vg. Athyros et al., SAFETY AND EFFICACY OF LONG-TERM STATIN-FIBRATE COMBINATIONS IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPIDEMIA, The American journal of cardiology, 80(5), 1997, pp. 608-613
PILOT-STUDY OF THE EFFECT OF THE SIMVASTATIN-CIPROFIBRATE COMBINATIONON MYOCARDIAL-INFARCTION RISK PROFILE IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPIDEMIA
Authors: ATHYROS VG PAPAGEORGIOU AA BASAGIANNIS EC LAFARAS CT KONTOPOULOS AG
Citation: Vg. Athyros et al., PILOT-STUDY OF THE EFFECT OF THE SIMVASTATIN-CIPROFIBRATE COMBINATIONON MYOCARDIAL-INFARCTION RISK PROFILE IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPIDEMIA, Clinical drug investigation, 11(4), 1996, pp. 196-204
EFFECTS OF SIMVASTATIN AND CIPROFIBRATE ALONE AND IN COMBINATION ON LIPID PROFILE, PLASMA-FIBRINOGEN AND LOW-DENSITY-LIPOPROTEIN PARTICLE STRUCTURE AND DISTRIBUTION IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA AND CORONARY-ARTERY DISEASE
Authors: KONTOPOULOS AG ATHYROS VG PAPAGEORGIOU AA HATZIKONSTANDINOU HA MAYROUDI MC BOUDOULAS H
Citation: Ag. Kontopoulos et al., EFFECTS OF SIMVASTATIN AND CIPROFIBRATE ALONE AND IN COMBINATION ON LIPID PROFILE, PLASMA-FIBRINOGEN AND LOW-DENSITY-LIPOPROTEIN PARTICLE STRUCTURE AND DISTRIBUTION IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA AND CORONARY-ARTERY DISEASE, Coronary artery disease, 7(11), 1996, pp. 843-850
EFFECT OF QUINAPRIL OR METOPROLOL ON HEART-RATE-VARIABILITY IN POSTMYOCARDIAL INFARCTION PATIENTS
Authors: KONTOPOULOS AG ATHYROS VG PAPAGEORGIOU AA PAPADOPOULOS GV AVRAMIDIS MJ BOUDOULAS H
Citation: Ag. Kontopoulos et al., EFFECT OF QUINAPRIL OR METOPROLOL ON HEART-RATE-VARIABILITY IN POSTMYOCARDIAL INFARCTION PATIENTS, The American journal of cardiology, 77(4), 1996, pp. 242-246
HOLT-ORAM SYNDROME WITH MALFORMATIONS OF RENAL AND CEREBRAL-ARTERIES
Authors: KOUTLAS ED PAPAGEORGIOU AA ATHYROS VG
Citation: Ed. Koutlas et al., HOLT-ORAM SYNDROME WITH MALFORMATIONS OF RENAL AND CEREBRAL-ARTERIES, Acta cardiologica, 51(4), 1996, pp. 373-376
LONG-TERM EFFECT OF GEMFIBROZIL ON CORONARY HEART-DISEASE RISK PROFILE OF PATIENTS WITH PRIMARY COMBINED HYPERLIPIDEMIA
Authors: ATHYROS VG PAPAGEORGIOU AA AVRAMIDIS MJ KONTOPOULOS AG
Citation: Vg. Athyros et al., LONG-TERM EFFECT OF GEMFIBROZIL ON CORONARY HEART-DISEASE RISK PROFILE OF PATIENTS WITH PRIMARY COMBINED HYPERLIPIDEMIA, Coronary artery disease, 6(3), 1995, pp. 251-256
COMBINED TREATMENT WITH PRAVASTATIN AND GEMFIBROZIL IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPEMIA - A CLINICAL-STUDY
Authors: ATHYROS VG PAPAGEORGIOU AA HAGIKONSTANTINOU HJ PAPADOPOULOS GV ZAMBOULIS CX KONTOPOULOS AG
Citation: Vg. Athyros et al., COMBINED TREATMENT WITH PRAVASTATIN AND GEMFIBROZIL IN PATIENTS WITH REFRACTORY FAMILIAL COMBINED HYPERLIPEMIA - A CLINICAL-STUDY, Drug investigation, 7(3), 1994, pp. 134-142
EFFECT OF PRAVASTATIN IN THE PREVENTION OF CORONARY HEART-DISEASE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
Authors: ATHYROS VG PAPAGEORGIOU AA AVRAMIDIS MJ KARAYANNIS AJ ZAMBOULIS CX KONTOPOULOS AG
Citation: Vg. Athyros et al., EFFECT OF PRAVASTATIN IN THE PREVENTION OF CORONARY HEART-DISEASE IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA, Current therapeutic research, 55(8), 1994, pp. 914-924
Risultati: 1-12 |